000 01633 a2200481 4500
005 20250517092643.0
264 0 _c20170828
008 201708s 0 0 eng d
022 _a1432-0428
024 7 _a10.1007/s00125-016-3958-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWu, Hao
245 0 0 _aC66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21.
_h[electronic resource]
260 _bDiabetologia
_c07 2016
300 _a1558-1568 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBlood Pressure
_xgenetics
650 0 4 _aBlotting, Western
650 0 4 _aCurcumin
_xtherapeutic use
650 0 4 _aDiabetes Mellitus, Experimental
_xdrug therapy
650 0 4 _aDiabetic Nephropathies
_xdrug therapy
650 0 4 _aHeterozygote
650 0 4 _aKelch-Like ECH-Associated Protein 1
_xgenetics
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aNF-E2-Related Factor 2
_xgenetics
700 1 _aKong, Lili
700 1 _aTan, Yi
700 1 _aEpstein, Paul N
700 1 _aZeng, Jun
700 1 _aGu, Junlian
700 1 _aLiang, Guang
700 1 _aKong, Maiying
700 1 _aChen, Xiangmei
700 1 _aMiao, Lining
700 1 _aCai, Lu
773 0 _tDiabetologia
_gvol. 59
_gno. 7
_gp. 1558-1568
856 4 0 _uhttps://doi.org/10.1007/s00125-016-3958-8
_zAvailable from publisher's website
999 _c25959842
_d25959842